相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non pharmacological interventions for spasticity in multiple sclerosis
Bhasker Amatya et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
W. Notcutt et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotna et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Neurolytic phenol blockade of the obturator nerve for severe adductor spasticity
T. Akkaya et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2010)
THE EFFECT OF DANTRIUM®* ON SPASTICITY IN MULTIPLE SCLEROSIS
Herbert Ladd et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
A DOUBLE-BLIND TRIAL WITH BACLOFEN (LIORESAL®) AND DIAZEPAM IN SPASTICITY DUE TO MULTIPLE SCLEROSIS
Arne From et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Nightly Sublingual Tizanidine HCl in Multiple Sclerosis: Clinical Efficacy and Safety
Veronika Vakhapova et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
Matthias Karst et al.
DRUGS (2010)
Stop using the Ashworth Scale for the assessment of spasticity
J. F. M. Fleuren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
Derick T. Wade et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Quantifying repeatability of the Wartenberg pendulum test parameters in children with spasticity
Malgorzata Syczewska et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
Adverse effects of medical cannabinoids: a systematic review
Tongtong Wang et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: A post hoc analysis of a randomized, double-blind, placebo-controlled trial
John T. Farrar et al.
CLINICAL THERAPEUTICS (2008)
Intrathecal phenol: an old treatment revisited
Colin Pinder et al.
DISABILITY AND REHABILITATION (2008)
A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury
Leonard Kamen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
C. Collin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Spasticity-assessment: a review
F. Biering-Sorensen et al.
SPINAL CORD (2006)
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain -: A double-blind placebo-controlled cross-over trial
Joerg Wissel et al.
JOURNAL OF NEUROLOGY (2006)
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
D. T. Wade et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
A systematic review of the Tardieu Scale for the measurement of spasticity
A. B. Haugh et al.
DISABILITY AND REHABILITATION (2006)
Management of spasticity in adults: practical application of botulinum toxin
MS Pathak et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
E Russo et al.
MEDICAL HYPOTHESES (2006)
Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)
JC Hobart et al.
BRAIN (2006)
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
JP Zajicek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature
T Platz et al.
DISABILITY AND REHABILITATION (2005)
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004
M Brainin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
A benefit-risk assessment of baclofen in severe spinal spasticity
A Dario et al.
DRUG SAFETY (2004)
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
C Vaney et al.
MULTIPLE SCLEROSIS (2004)
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
DT Wade et al.
MULTIPLE SCLEROSIS (2004)
Prevalence and treatment of spasticity reported by multiple sclerosis patients
MA Rizzo et al.
MULTIPLE SCLEROSIS (2004)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
DT Wade et al.
CLINICAL REHABILITATION (2003)
Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role?
L Jarrett et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
J Killestein et al.
NEUROLOGY (2002)
Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis:: a prospective, randomised, double blind, placebo controlled, dose ranging study
N Hyman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Effect of baclofen on gait in spastic MS patients
GB Orsnes et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
Gabapentin effect on spasticity in multiple sclerosis: A placebo-controlled, randomized trial
NC Cutter et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2000)
分享论文
